Clinical trial
Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness
NCT01018225 is registered in ClinicalTrials.gov with Cognitive Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness
- Lead sponsor
- Cognitive Research Corporation
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- November 30, 2009
- Completion date
- July 31, 2010
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.